Extramammary Paget disease
ek-struh-MAM-uh-ree PAJ-it dih-ZEEZ
Also known as: EMPD, Extramammary Paget's disease
At a Glance
What is Extramammary Paget disease?
Extramammary Paget disease is a rare skin condition that primarily affects areas with apocrine glands, such as the genital and anal regions. It is caused by the presence of malignant cells in the epidermis. Over time, the disease can progress from a localized skin condition to invasive cancer. Early symptoms include itchy, red, and scaly patches on the skin, which can be mistaken for eczema or dermatitis. As the disease advances, lesions may become ulcerated and painful. Early diagnosis is critical to prevent progression to invasive cancer and to improve treatment outcomes. The condition can be challenging for affected individuals and their families, as it often requires multiple treatments and can impact quality of life. Prognosis varies depending on whether the disease is localized or has spread to other areas. Daily life for those affected may involve managing symptoms and undergoing regular medical check-ups. Treatment options include surgery, radiation, and topical therapies. Support from healthcare professionals and family is essential for coping with the disease. Awareness and education about the condition can aid in early detection and management.
Medical Definition
Extramammary Paget disease is a rare cutaneous adenocarcinoma characterized by the presence of malignant glandular cells in the epidermis. Histologically, it presents as large cells with abundant pale cytoplasm and prominent nuclei, often forming clusters or nests within the epidermis. It is classified as a primary cutaneous adenocarcinoma or secondary to an underlying malignancy. Epidemiologically, it predominantly affects postmenopausal women and older men, with a higher incidence in Caucasians. The disease course can range from indolent to aggressive, with potential for local invasion and metastasis. Management requires a multidisciplinary approach, often involving surgical excision and adjunctive therapies.
Extramammary Paget disease Symptoms
Symptoms vary in severity between individuals. Early diagnosis and management can significantly improve outcomes.
Very Common
Itching manifests as an intense and persistent urge to scratch the affected area. This sensation is caused by the infiltration of Paget cells into the epidermis, triggering an inflammatory response. Over time, the itching may become more severe and disrupt sleep patterns. Patients can manage this symptom with topical corticosteroids and antihistamines to reduce inflammation and itchiness.
Redness appears as a noticeable erythematous patch on the skin, often with well-defined borders. This occurs due to increased blood flow and inflammation in response to the presence of malignant cells. As the condition progresses, the redness may expand and become more pronounced. Patients may find this symptom distressing, and it can be managed with topical treatments aimed at reducing inflammation.
Scaling is characterized by the formation of dry, flaky skin on the affected area. This results from the abnormal proliferation and shedding of skin cells due to the underlying malignancy. Over time, the scaling may lead to skin thickening and discomfort. Regular use of emollients and keratolytic agents can help manage this symptom by keeping the skin moisturized and reducing flakiness.
Common
Pain in extramammary Paget disease often presents as a burning or stinging sensation in the affected area. This is caused by nerve irritation and inflammation due to the presence of cancerous cells. As the disease progresses, the pain may become more persistent and severe. Pain management strategies include topical anesthetics and systemic analgesics to provide relief.
Ulceration appears as open sores or lesions on the skin, often accompanied by oozing or bleeding. This occurs when the integrity of the skin is compromised by the invasive growth of Paget cells. Over time, these ulcers may enlarge and become prone to infection. Treatment involves wound care and, in some cases, surgical intervention to remove affected tissue.
Thickening of the skin, or lichenification, results in a leathery texture and increased prominence of skin markings. This is due to chronic inflammation and scratching, leading to skin cell proliferation. As the condition progresses, the thickening may become more pronounced and affect skin flexibility. Management includes topical steroids and moisturizers to reduce inflammation and improve skin texture.
Less Common
Bleeding occurs when the fragile skin overlying the affected area is damaged, leading to rupture of small blood vessels. This is often a result of scratching or trauma to the delicate skin. Over time, repeated bleeding episodes can lead to anemia and increased risk of infection. Patients are advised to protect the skin and use gentle cleansing methods to minimize bleeding.
Swelling manifests as localized edema in the area surrounding the lesions. This is due to the accumulation of fluid as part of the inflammatory response to the cancerous cells. Over time, swelling can lead to discomfort and restrict movement, particularly if it occurs in areas like the groin. Management includes elevation, compression, and anti-inflammatory medications to reduce swelling.
What Causes Extramammary Paget disease?
Extramammary Paget disease (EMPD) is primarily associated with mutations in the HRAS and KRAS genes, located on chromosomes 11p15.5 and 12p12.1, respectively. These genes encode proteins that are part of the RAS/MAPK signaling pathway, which regulates cell proliferation, differentiation, and survival. Mutations in HRAS and KRAS lead to constitutive activation of the RAS proteins, resulting in continuous cell signaling that promotes uncontrolled cell growth. This aberrant signaling disrupts normal cellular homeostasis and can lead to the accumulation of additional genetic alterations. The immediate molecular consequence is the dysregulation of cell cycle control, contributing to the neoplastic transformation of epithelial cells. Organelle dysfunction, such as mitochondrial stress, may occur due to altered metabolic demands of rapidly proliferating cells. This can lead to a microenvironment that favors tumor progression and invasion. The immune response, particularly involving T-cells and macrophages, may be activated in an attempt to target the abnormal cells, but chronic inflammation can paradoxically support tumor growth. Neuroinflammation is not a primary feature of EMPD, but local immune responses can contribute to tissue damage. Degeneration of white matter is not typical in EMPD, as it primarily affects the skin and mucosal surfaces. Symptoms such as itching, redness, and lesions appear in specific patterns due to the localization of affected apocrine gland-rich areas. Variability in disease severity among patients can be attributed to differences in genetic background, the extent of mutations, and immune system interactions. The presence of secondary infections or co-existing skin conditions can also influence the clinical presentation. Understanding these molecular and cellular mechanisms is crucial for developing targeted therapies for EMPD.
How is Extramammary Paget disease Diagnosed?
Typical age of diagnosis: Extramammary Paget disease is typically diagnosed in individuals over the age of 50, with a higher prevalence in females. Diagnosis often occurs after patients present with persistent skin lesions that resemble eczema or dermatitis, particularly in areas such as the vulva, perianal region, or scrotum. A delay in diagnosis is common due to the rarity of the condition and its resemblance to more common dermatological issues. Early and accurate diagnosis is crucial for effective management and improved outcomes.
Clinicians look for erythematous, scaly, and well-demarcated plaques in the anogenital region. A detailed patient history is essential, focusing on the duration and progression of skin lesions and any associated symptoms such as itching or burning. Physical examination may reveal lesions that are moist and eczematous, often leading to a misdiagnosis of dermatitis. This step helps determine the need for further diagnostic testing and guides the clinician toward considering Paget disease in the differential diagnosis.
Magnetic Resonance Imaging (MRI) is often used to assess the extent of the disease and any underlying malignancies. MRI can show thickening of the skin and subcutaneous tissues, which are indicative of Paget disease. These findings help confirm the diagnosis and exclude other conditions such as melanoma or squamous cell carcinoma. Imaging is crucial for surgical planning and assessing the need for further intervention.
A skin biopsy is the definitive laboratory test ordered to confirm the diagnosis of Extramammary Paget disease. Immunohistochemical staining for markers such as CK7, CEA, and GCDFP-15 is performed to identify Paget cells. Abnormal results show large, pale-staining cells within the epidermis, confirming the presence of Paget disease. These results guide the clinician in determining the appropriate treatment strategy and the need for additional testing.
Genetic testing may involve sequencing genes such as HER2/neu to identify potential mutations associated with Paget disease. Mutations in these genes can confirm the diagnosis and suggest a potential target for therapy. Results from genetic testing can also inform family counseling by identifying hereditary patterns. This information is valuable for assessing the risk of recurrence and guiding personalized treatment plans.
Extramammary Paget disease Treatment Options
The drug class used is topical chemotherapeutic agents, such as 5-fluorouracil or imiquimod. These agents work by inhibiting DNA synthesis in rapidly dividing cells, targeting the abnormal Paget cells. Clinical evidence shows that these drugs can reduce lesion size and symptom severity in some patients. However, their efficacy is variable, and side effects such as local irritation and erythema are common. Limitations include incomplete response and the need for prolonged treatment duration.
Specific techniques include biofeedback and pelvic floor exercises to improve muscle strength and coordination. The therapeutic goal is to alleviate discomfort and improve quality of life by reducing symptoms such as pain and urinary incontinence. Sessions are typically conducted weekly for several months, with measurable outcomes including increased muscle tone and reduced symptom severity. Long-term benefits include enhanced pelvic function and improved patient-reported outcomes. Physical therapy is an adjunct to other treatments and not a standalone therapy.
Surgery is indicated for localized disease that has not responded to conservative treatments. The procedure involves excising the affected skin with a margin of healthy tissue to ensure complete removal of Paget cells. Expected benefits include a high likelihood of disease clearance and reduced risk of recurrence. Surgical risks include infection, scarring, and potential impact on function depending on the excision site. Post-operative care involves wound management and regular follow-up to monitor for recurrence.
The care team typically includes dermatologists, oncologists, surgeons, and mental health professionals. Specific interventions focus on symptom management, psychological support, and coordination of care. Psychosocial support strategies may involve counseling and support groups to address the emotional impact of the disease. Family education is crucial to help caregivers understand the condition and its management. Long-term monitoring plans include regular follow-ups and surveillance to detect any signs of recurrence early.
When to See a Doctor for Extramammary Paget disease
- Sudden severe pain in the affected area — this could indicate an aggressive progression or secondary infection requiring immediate medical attention.
- Rapidly spreading rash or lesion — suggests possible invasive disease that needs urgent evaluation.
- Difficulty urinating or blood in urine — could indicate involvement of deeper tissues or organs, necessitating emergency care.
- Persistent itching or irritation — may indicate disease progression and should be evaluated by a healthcare provider.
- New or changing lesions — could suggest disease recurrence or progression, warranting a follow-up appointment.
- Unexplained weight loss — may be a sign of systemic involvement or malignancy, and should be discussed with a doctor.
- Mild irritation or redness — monitor for changes and maintain good hygiene, consult a doctor if it worsens.
- Occasional discomfort — keep track of frequency and triggers, and discuss with a healthcare provider during routine visits.
Extramammary Paget disease — Frequently Asked Questions
Is this condition hereditary?
Extramammary Paget disease is not typically hereditary and does not follow a clear inheritance pattern. The probability of passing it to children is considered low. De novo mutations are not commonly associated with this condition. Carrier status implications are minimal since it is not a genetic disorder. Genetic counseling is generally not necessary but may be considered if there are concerns about familial cancer syndromes.
What is the life expectancy for someone with this condition?
Life expectancy can vary depending on the age of onset and whether the disease is localized or invasive. Early detection and treatment generally improve outcomes. Mortality is often related to invasive disease or associated malignancies. Treatment can significantly enhance survival rates, especially when initiated early. Realistic expectations should include regular follow-ups and monitoring for recurrence.
How is this condition diagnosed and how long does diagnosis take?
Diagnosis typically involves a combination of clinical examination, biopsy, and histopathological analysis. The time from first symptoms to diagnosis can vary, often taking several months due to the rarity of the condition. Dermatologists and oncologists are commonly consulted during the diagnostic process. Delayed diagnosis is often due to misidentification as eczema or dermatitis. A biopsy confirming Paget cells is essential for a definitive diagnosis.
Are there any new treatments or clinical trials available?
Current research is exploring targeted therapies and immunotherapy as promising approaches. Gene therapy is not yet applicable, but novel topical and systemic treatments are under investigation. ClinicalTrials.gov is a useful resource for finding ongoing trials. Patients should ask their doctors about eligibility for trials and potential benefits. New treatments may become available within the next few years, but timelines can vary.
How does this condition affect daily life and activities?
Extramammary Paget disease can impact mobility and self-care due to discomfort and lesions. Educational activities may be disrupted by medical appointments and treatment side effects. Social and emotional challenges include coping with a rare diagnosis and potential stigma. Family burden can be significant, requiring support and understanding. Supports such as counseling, support groups, and adaptive clothing can be beneficial.
Learn More
Support & Resources
References
Content generated with support from peer-reviewed literature via PubMed.
- 1.Evidence-Based Clinical Practice Guidelines for Extramammary Paget Disease.
Kibbi N, Owen JL, Worley B et al. · JAMA Oncol · 2022 · PMID: 35050310
- 2.Extramammary Paget disease.
St Claire K, Hoover A, Ashack K et al. · Dermatol Online J · 2019 · PMID: 31046904
- 3.Extramammary Paget Disease.
Merritt BG, Degesys CA, Brodland DG · Dermatol Clin · 2019 · PMID: 31084720
- 4.Extramammary Paget disease. Part I. epidemiology, pathogenesis, clinical features, and diagnosis.
Shah RR, Shah K, Wilson BN et al. · J Am Acad Dermatol · 2024 · PMID: 38704032
- 5.Extramammary Paget's Disease.
Asel M, LeBoeuf NR · Hematol Oncol Clin North Am · 2019 · PMID: 30497678
- 6.Extramammary Paget disease. Part II. Evidence-based approach to management.
Shah RR, Shah K, Wilson BN et al. · J Am Acad Dermatol · 2024 · PMID: 38588817
- 7.Extramammary Paget disease of the vulva.
Konstantinova AM, Kazakov DV · Semin Diagn Pathol · 2021 · PMID: 32921571
- 8.Extramammary Paget Disease: a Therapeutic Challenge, for a Rare Entity.
Pérez JC, Salgado AC, Pérez-Mies B et al. · Curr Oncol Rep · 2023 · PMID: 37421583
This content is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.Last reviewed: 2026-06-06